Our Members
Administration
 | Dr. Mukund Sibi The Center is led by Dr. Mukund P. Sibi, James A. Meier and University Distinguished Professor, and 2008 winner of the Arthur C. Cope Scholar Award. Dr. Sibi was key to the program’s inception in 2001. | |
Charlene de Celle charlene.decelle@ndsu.edu Charlene de Celle joined the Center for Protease Research in August 2014. She holds a B.S. in Business Management from Arizona State University. | ||
External Advisory Board Members
 | Dr. Jeffrey Aube University Distinguished Professor of Medicinal Chemistry University of Kansas Specialized Chemistry Center 2034 Becker Drive Structural Biology Center, West Campus Lawrence, KS 66047 | |
 | Dr. James B. McCarthy University of Minnesota Department of Laboratory Medicine and Pathology MMC 609 Mayo 8609 420 Delaware Minneapolis, MN 55455 | |
 | Dr. Danny R. Welch University of Kansas Medical Center Adjunct Faculty of Department of Molecular & Integrative Physiology 2003 Wahl Hall West 3901 Rainbow Blvd Kansas City, KS 68160 |
Core Facility Managers
 | Dr. Tao Wang Tao is the manager of our Core Biology Facility, which includes Tissue Culture, Molecular Biology, and Bioassay labs. |
Investigators
 | Dr. Bin Guo Dr. Guo has established a research program to study the regulation of cancer cell apoptosis. He is interested in the investigation of the molecular mechanisms that control cancer cell death in response to chemotherapeutic drugs. | |
 | Dr. Katie Reindl Dr. Reindl has developed a research program to investigate the effects of dietary phytochemicals on cancer cell behavior. She is interested in understanding the underlying molecular mechanisms by which these agents, alone or in combination with chemo and radiation therapies, prevent the progression of various solid tumors. | |
 | Teresa Bergholz | |
 | Dr. Estelle Leclerc Dr. Leclerc is interested in understanding the role of the Receptor for Advanced Glycation End Products (RAGE) in cancer. RAGE promotes tumor growth and metastasis formation in many cancers. Her group is focusing on two aggressive cancers: pancreatic adenocarcinoma and melanoma. She has developed a panel of monoclonal antibodies that can block the activation of the receptor by its ligands and is currently testing the effect of these antibodies in animal models. | |
 | Dr. Sheela Ramamoorthy | |
Past Investigators
 | Dr. Gregory Cook Dr. Cook has initiated a vigorous program in the application of organometallic catalysis to organic synthesis with a focus on the preparation of unnatural amino acids. His group will use their amino acid expertise in the development of new protease inhibitors. | |
 | Dr. Glenn Dorsam Dr. Dorsam has established a research program based on the epigenetic transcriptional regulation controlling how cells proliferate and differentiate. He is specifically interested in the investigation of molecular mechanisms governing Ikaros-mediated transcriptional regulation of vasoactive intestinal peptide receptor-1 (VPACR-1) in T lymphocytes. | |
 | Dr. Stuart Haring | |
 | Dr. John McEvoy Pathogenic Microbiology. Research Interests: Cryptosporidium virulence factors and mechanisms of pathogenesis. Academic Interests: Microbial pathogenesis. | |
 | Dr. Steven Qian Dr. Qian is studying the roles of free radical metabolites from lipid peroxidation during progression/treatment of human diseases, including cancer. His group developed and utilizes a novel technique, HPLC/ESR/MS, along with molecular biological techniques to assess the relationship between lipid-derived inflammatory molecules and COX/LOX expression during disease development/treatment. | |
 | Dr. Jane Schuh Dr. Schuh’s research program examines the development and maintenance of allergic asthma in an experimental murine model. She is particularly interested in the biology of chronic outcomes of the disease. | |
 | Dr. Christopher Colbert | |
 | Dr. Nathan Fisher | |
 | Dr. Kendra Greenlee Insect Physiology and Immunology. Research interests include body size variation and respiratory system physiology in insects, with an emphasis on the effects of hypoxia on respiratory functions and molting. I am also interested in insect immunity and the response to bacterial and parasite infections. | |
 | Dr. Yagna Jarajapu | |
 | Dr. Guodong Liu | |
 | Dr. Kenton Rodgers | |
 | Dr. Sangita Sinha Research interests are in structural biology with a focus on autophagy. | |
 | Dr. Chengwen Sun Cardiovascular Pharmacology. My current research is focused on central blood pressure regulation and pathogenesis of hypertension to identify novel targets for the treatment of hypertension and other cardiovascular diseases. | |
 | Dr. Erxi Wu erxi.wu@ndsu.edu |